Telsey Advisory Group Issues Positive Forecast for CAVA Group (NYSE:CAVA) Stock Price
CAVA Group (NYSE:CAVA – Get Free Report) had its price target boosted by equities research analysts at Telsey Advisory Group from $92.00 to $95.00 in a research note issued on Wednesday. The firm presently has an “outperform” rating on the stock. Telsey Advisory Group’s price objective would suggest a potential upside of 16.91% from the […]
JPMorgan Chase & Co. Issues Positive Forecast for Federal Realty Investment Trust (NYSE:FRT) Stock Price
Federal Realty Investment Trust (NYSE:FRT – Get Free Report) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from $115.00 to $124.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the real estate investment trust’s stock. JPMorgan Chase & Co.‘s price objective […]
Telsey Advisory Group Issues Positive Forecast for CAVA Group (NYSE:CAVA) Stock Price
CAVA Group (NYSE:CAVA – Get Free Report) had its price objective upped by research analysts at Telsey Advisory Group from $88.00 to $92.00 in a research note issued on Thursday. The firm currently has an “outperform” rating on the stock. Telsey Advisory Group’s price target would indicate a potential upside of 27.36% from the company’s […]
JPMorgan Chase & Co. Issues Pessimistic Forecast for Hims & Hers Health (NYSE:HIMS) Stock Price
Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price target reduced by analysts at JPMorgan Chase & Co. from $35.00 to $33.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of […]
JPMorgan Chase & Co. Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price
Haemonetics (NYSE:HAE – Get Free Report) had its target price reduced by stock analysts at JPMorgan Chase & Co. from $74.00 to $62.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “neutral” rating on the medical instruments supplier’s stock. JPMorgan Chase & Co.‘s target price indicates a potential […]
Wells Fargo & Company Issues Positive Forecast for Eversource Energy (NYSE:ES) Stock Price
Eversource Energy (NYSE:ES – Free Report) had its price target increased by Wells Fargo & Company from $74.00 to $75.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an overweight rating on the utilities provider’s stock. ES has been the subject of a number of other reports. UBS Group lowered their […]
Piper Sandler Issues Positive Forecast for Block (NYSE:XYZ) Stock Price
Block (NYSE:XYZ – Get Free Report) had its price target upped by investment analysts at Piper Sandler from $51.00 to $58.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has an “underweight” rating on the technology company’s stock. Piper Sandler’s target price points to a potential downside of 22.30% from the stock’s […]
JPMorgan Chase & Co. Issues Pessimistic Forecast for Parker-Hannifin (NYSE:PH) Stock Price
Parker-Hannifin (NYSE:PH – Get Free Report) had its price objective reduced by stock analysts at JPMorgan Chase & Co. from $1,100.00 to $1,060.00 in a research note issued on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the industrial products company’s stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of […]
JPMorgan Chase & Co. Issues Positive Forecast for Corning (NYSE:GLW) Stock Price
Corning (NYSE:GLW – Get Free Report) had its target price boosted by JPMorgan Chase & Co. from $175.00 to $185.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the electronics maker’s stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 1.42% from the stock’s current […]
BNP Paribas Exane Issues Positive Forecast for Corteva (NYSE:CTVA) Stock Price
Corteva (NYSE:CTVA – Get Free Report) had its target price boosted by investment analysts at BNP Paribas Exane from $74.00 to $77.00 in a report issued on Wednesday,MarketScreener reports. BNP Paribas Exane’s price target indicates a potential downside of 3.84% from the stock’s current price. A number of other equities analysts have also recently issued […]
last updated on 20 May 22:02